EARNEST PARTNERS LLC 13D and 13G filings for Meridian Bioscience, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-08-10 10:22 am Sale | 2022-07-31 | 13G | Meridian Bioscience, Inc. VIVO | EARNEST PARTNERS LLC | 138,110 0.300% | -3,586,200 (-96.29%) | Filing |
| 2022-02-10 08:53 am Sale | 2021-12-31 | 13G | Meridian Bioscience, Inc. VIVO | EARNEST PARTNERS LLC | 3,724,310 8.600% | -617,524 (-14.22%) | Filing |
| 2021-04-12 4:56 pm Purchase | 2021-03-31 | 13G | Meridian Bioscience, Inc. VIVO | EARNEST PARTNERS LLC | 4,341,834 10.100% | 4,341,834 (New Position) | Filing |